In this study, we determined expression levels of signaling factors in the PI3K/AKT/mTOR pathway in patients with HNSCC with or without recurrence who had previously received definitive surgery and adjuvant radiotherapy. Here, MTOR is linked to head and neck squamous cell carcinoma.